News > South African COVID-19 variant can better bypass Pfizer-BioNTech vaccine: Israeli study

South African COVID-19 variant can better bypass Pfizer-BioNTech vaccine: Israeli study

The South African coronavirus variant is better at "breaking through" the defences of the Pfizer/BioNTech vaccine than other forms of the virus, Israeli experts said Sunday.

Among the 150 people in the study who were fully vaccinated and had COVID-19, "the prevalence rate (of the South African variant) was eight times higher than the rate in the unvaccinated (individuals)," the study said.